|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash and cash equivalents | |||||||
| Due from sponsor | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | |||||||
| Restricted Cash | |||||||
| Accounts Receivable, Net | |||||||
| Inventories | |||||||
| Prepaid Expenses | |||||||
| Other Current Assets | |||||||
| Total Current Assets | |||||||
| Long-term prepaid insurance | |||||||
| Marketable securities held in Trust Account | |||||||
| Long-Term Assets | |||||||
| Restricted Cash | |||||||
| Property, Plant, and Equipment, Net | |||||||
| Operating Lease Right of Use Assets, Net | |||||||
| Goodwill, Net | |||||||
| Intangible asset, finite-lived, after accumulated amortization | |||||||
| Internally developed software | |||||||
| Trade names | |||||||
| Other Assets | |||||||
| Total Long-Term Assets | |||||||
| Total Assets | |||||||
| Liabilities and Stockholders’ Equity | |||||||
| Current Liabilities | |||||||
| Accounts Payable | |||||||
| Accrued Expenses | |||||||
| Accrued offering costs | |||||||
| Deferred Revenue | |||||||
| Contingent Consideration | |||||||
| Short-Term Debt and Current Portion of Long-Term Debt | |||||||
| Current Portion of Operating Lease Obligations | |||||||
| Other Current Liabilities | |||||||
| Total Current Liabilities | |||||||
| PIPE Subscription Agreements liability | |||||||
| Deferred advisory fee | |||||||
| Long-Term Liabilities | |||||||
| Warrant Liability | |||||||
| Contingent Consideration | |||||||
| Long-Term Debt, Net | |||||||
| Long-Term Operating Lease Obligations | |||||||
| Derivative liability, noncurrent | |||||||
| Earnout Shares and Deferred Founder Shares | |||||||
| Forward Purchase Agreement Liability | |||||||
| Other Long-Term Liabilities | |||||||
| Total Long-Term Liabilities | |||||||
| Total Liabilities | |||||||
| Redeemable Noncontrolling Interests | |||||||
| Perpetual Non-Convertible Preferred Stock, $0.0001 par value, 300,000 shares authorized, 225,000 issued and outstanding as of September 30, 2026 (aggregate liquidation preference of $225.0 million); no shares authorized, issued and outstanding as of December 31, 2025 (Note 14) | |||||||
| Stockholders’ Equity | |||||||
| Common Stock, $0.0001 par value, 450,000,000 shares authorized, 72,416,056 issued and outstanding as of September 30, 2026; 97,899,711 shares authorized, 49,180,937 shares issued and outstanding as of December 31, 2025 | |||||||
| Class B Ordinary Shares | |||||||
| Total common Stock, $0.0001 par value, 450,000,000 shares authorized, 72,416,056 issued and outstanding as of September 30, 2026; 97,899,711 shares authorized, 49,180,937 shares issued and outstanding as of December 31, 2025 | |||||||
| Additional Paid-In Capital | |||||||
| Accumulated Deficit | |||||||
| Accumulated Other Comprehensive Loss | |||||||
| Total Stockholders’ Equity | |||||||
| Noncontrolling Interests | |||||||
| Total Equity | |||||||
| Total Liabilities and Stockholders’ Equity |
Loading...